Arena Pharmaceuticals Inc
ARNA
ARNA was delisted on the 10th of March, 2022.
131 hedge funds and large institutions have $645M invested in Arena Pharmaceuticals Inc in 2014 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 48 increasing their positions, 31 reducing their positions, and 22 closing their positions.
55% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 31
3% more capital invested
Capital invested by funds: $629M → $645M (+$15.9M)
5% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 22
2% less funds holding
Funds holding: 134 → 131 (-3)
46% less call options, than puts
Call options by funds: $29.8M | Put options by funds: $54.7M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OppenheimerFunds
New York
|
+$6.63M |
| 2 |
Goldman Sachs
New York
|
+$5.93M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$4.16M |
| 4 |
CA
Commerzbank Aktiengesellschaft
Frankfurt,
Germany
|
+$2.42M |
| 5 |
Morgan Stanley
New York
|
+$2.33M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SC
Samlyn Capital
New York
|
-$21.4M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
-$16.4M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.12M |
| 4 |
VanEck Associates
New York
|
-$3.44M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$3.37M |
ARNA Hedge Fund Activity: Q1 2014 in Review
131 of the 3,462 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q1 2014, worth a combined $645M — up 2.5% from $629M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of ARNA and 21 opened new positions — a net loss of 1 holder — while 31 trimmed existing stakes and 48 added.
The largest buyer was OppenheimerFunds, adding an estimated $6.63M. The largest seller was Samlyn Capital, exiting entirely with an estimated $21.4M sold.
- 131 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q1 2014, down from 134 in Q4 2013.
- Funds reported $645M of Arena Pharmaceuticals Inc stock for Q1 2014, up 2.5% quarter-over-quarter.
- 21 funds opened new Arena Pharmaceuticals Inc positions in Q1 2014 and 22 closed out, a net change of -1 holder.
- The largest Arena Pharmaceuticals Inc buyer in Q1 2014 was OppenheimerFunds, an estimated $6.63M added.
- The largest Arena Pharmaceuticals Inc seller in Q1 2014 was Samlyn Capital, an estimated $21.4M sold.
Based on aggregated 13F filings for Q1 2014.